Ruti Aga's forged prescription: six years, and a defence destroyed on paper

The clinic did not exist. The pad on which the prescription was written, allegedly, was an old one from a former workplace. The person who wrote it was a family member of Ruti Aga, with no medical registration and no clinical standing. Those three details sit in the Athletics Integrity Unit's statement issued on Thursday, and the whole arithmetic of the six-year ban on the Ethiopian marathoner fits inside them: two years for the presence of a prohibited substance, four years for tampering. A sanction that began with a medicine ended on a piece of paper. I watched the 2026 Tokyo Marathon on a laptop in a London student union common room with thirty-four people, and what carried that afternoon was not the split but the name — Ruti Aga, 2:20:40, a Major title. Seven years on, the same name is attached to a prescription that came out of a clinic which never existed. Sport's fastest route to ruin runs in one direction: body first, paper second, career last. Aga did not need an introduction. Three second-place finishes at World Marathon Majors, including roughly 2:18:34 in Berlin in 2026, and the 2026 Tokyo title place her in the tier that lives on Major podiums without ever being guaranteed a national vest. Ethiopia's women's marathon depth is such that a 2:18 performer cannot assume selection. The race that matters in this case is a half marathon in China in March, which she won. The report gives no time for it, and I will not invent one. What matters is that an in-competition test happened there, which means the event belonged to a World Athletics Label tier with a proper elite field and a testing window. For East African marathoners, the Chinese label circuit is a separate economy: decent appearance fees, a low race count, reliable income between Majors. It has also become the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races. The sanction architecture is standard. Two years for presence, the usual outcome when a Specified substance is found and intent is not established; four years for tampering, the Code's default. Six years in total, dated from 10 September, when the provisional suspension began. Backdating is not relief — provisional time is credited, never gifted. Here is the legal hinge most reporting got wrong. Methylprednisolone has been described as a prohibited steroid. It is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List, and S9 substances are prohibited in-competition only, by injection, oral or rectal route. A therapeutic knee injection out of competition is entirely lawful. It becomes a violation only when residues are present in an in-competition sample. That changes what a defence should have looked like. The argument was never "it wasn't a steroid"; it was route, dose and timing, documented. A road race's testing window opens at 23:59 the day before the race, so an injection given days earlier can still be caught. Any experienced team physician knows this and plans the washout around it. Intra-articular methylprednisolone for knee synovitis is standard sports medicine in distance runners, which is the bitter irony here: the exoneration that real records could have produced was destroyed by a forgery. Because the AIU's document check failed at three independent points. The clinic does not exist. The prescriber is an unregistered family member. The "old pad" claim was explicitly disowned by the clinic named on it. And the four-year tampering charge came from an interview, from answers given under questioning, not from a document alone. That detail matters: the substance case may well have been survivable, and it was lost in the room where the explanation was being offered. Add the consequence plainly. Age 32, a six-year ban, a return at roughly 38. Ethiopian women's marathon depth leaves no selection space for a 38-year-old with a doping record. Her record does not vanish by itself — the March race result and prize money are very likely void, but Tokyo 2026 and the Major podiums predate the violation, and the statement does not announce a finding of earlier use. The convenient version calls this rigour. The inverted version calls it disproportionate enforcement against African road runners, since the substance in question has no proven endurance benefit. Both have force and both miss the point. The enforcement frontier has moved from detection to document verification. The first question after a positive test is now whether the receipt, the prescription and the clinic record survive checking. That is the right direction for investigations, with a side effect: an athlete with no formal medical support may escape a substance case and will not escape a paper one. The structural question follows, and I am placing it as context, not as an excuse. Why was an internationally ranked marathoner operating without a credentialed team physician? Whose payroll — club, agent, management — carried her, and who on that payroll owned the medical duty of care? Indian readers know this question, because the athlete economy there runs on sports-quota jobs and scholarships. In the Ethiopian club-and-agent model the question inverts: money arrives from racing, and the medical structure does not follow it. The forged prescription filled that gap. Aga's name will now sit in the record alongside her 2:20:40 and alongside the date 10 September. The question is not whether two years were too many or too few. It is how many other women in the same training clusters carry no real record for a knee injection, only a trusted name who writes the slip. Next time someone wins a label race and walks into the mixed zone, ask for the medical file before the stride rate.